The PAR2-AP-mediated acute vasodilatation during ANG II infusion involves components of smooth muscle relaxation pathways that are resistant to the negative effects of endothelial dysfunction in cardiovascular disease. Here, F2RL1 is linked to cardiovascular disorder.